Auditor Mayer Hoffman McCann resigns as Unicycive's independent auditor

Unicycive Therapeutics, Inc.

Auditor MHM resigned effective upon earlier of new auditor engagement, filing of June 2023 Form 10-Q, or Aug 20, 2023.
No report modifications for FY 2022; no disagreements on accounting principles or audit scope during 2022 or through July 25, 2023.
Company previously reported material weakness in internal control over financial reporting as of Dec 31, 2022 due to lack of adequate staffing.
Company is currently interviewing other accounting firms to replace MHM as independent registered public accounting firm.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.